Vascularization of Human iPSC‐Derived Kidney Organoids Using Perfusion Culture, Pre‐Vascularized Collagen Scaffolds, and Decellularized Extracellular Matrix
Advanced Healthcare Materials · 2026-09 · 15 (33)
DOI: 10.1002/adhm.71526 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 10.08.2026. Verfasst von Helen Kearney und 5 weiteren Autor:innen. Beteiligte Einrichtung: MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, Maastricht, the Netherlands. Hauptthemen laut MEDLINE: Organoids, Kidney, Induced Pluripotent Stem Cells, Tissue Scaffolds. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Union's Horizon 2020 research and innovation programme.
Abstract (Originalsprache)
Human induced pluripotent stem cell‐derived kidney organoids represent promising in vitro models for studying kidney development and drug‐induced toxicity, yet their lack of vasculature limits maturation and translational use. Here, we present a proof‐of‐concept co‐culture platform to promote vascularization of kidney organoids by integrating stromal vascular fraction cells, collagen sponge scaffolds, porcine kidney decellularized extracellular matrix (dECM), and dynamic culture in a perfusion‐based U‐CUP bioreactor. We systematically evaluated the effects of serum supplementation, scaffold pre‐vascularization, dECM encapsulation, and flow conditions on organoid–vascular integration. Low‐level serum supplementation (1.5% FBS) sustained vascular networks without compromising organoid morphology. Perfusion supported vascular expansion; however, while a low flow rate comparable to interstitial tissue flow (0.01 mL/min) preserved organoid morphology and glomerular‐like structures, a higher flow rate optimized for vascularization (0.47 mL/min) disrupted overall organoid architecture. Encapsulation within dECM preserved glomerular morphology and supported vascular infiltration, whereas co‐culture with stromal vascular fraction cells enabled putative podocyte–endothelial interactions. Finally, exposure to the calcineurin inhibitor tacrolimus revealed dose‐dependent cytotoxicity and characteristic nephron and vascular injury, demonstrating the model's utility for nephrotoxicity screening. The established modular platform enables the engineering of vascularized kidney organoids, establishing foundations for physiologically relevant models for disease modeling and pre‐clinical drug testing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, Maastricht, the Netherlands.
- Department of Biomedical Engineering, University of Basel, Basel, Switzerland.
- Tissue Engineering, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.
ORCID-Profile: Helen Kearney, Andrea Mazzoleni, Ivan Martin, Lorenzo Moroni, Manuele Giuseppe Muraro, Carlos Mota
Förderung
- European Union's Horizon 2020 research and innovation programme
Zitieren
APA
Kearney, H., Mazzoleni, A., Martin, I., Moroni, L., Muraro, M. G., & Mota, C. (2026). Vascularization of Human iPSC‐Derived Kidney Organoids Using Perfusion Culture, Pre‐Vascularized Collagen Scaffolds, and Decellularized Extracellular Matrix. Advanced Healthcare Materials, 15(33). https://doi.org/10.1002/adhm.71526
Vancouver
Kearney H, Mazzoleni A, Martin I, Moroni L, Muraro MG, Mota C. Vascularization of Human iPSC‐Derived Kidney Organoids Using Perfusion Culture, Pre‐Vascularized Collagen Scaffolds, and Decellularized Extracellular Matrix. Advanced Healthcare Materials. 2026;15(33). doi:10.1002/adhm.71526
BibTeX
@article{Kearney2026,
author = {Kearney, Helen and Mazzoleni, Andrea and Martin, Ivan and Moroni, Lorenzo and Muraro, Manuele Giuseppe and Mota, Carlos},
title = {Vascularization of Human iPSC‐Derived Kidney Organoids Using Perfusion Culture, Pre‐Vascularized Collagen Scaffolds, and Decellularized Extracellular Matrix},
journal = {Advanced Healthcare Materials},
year = {2026},
volume = {15},
number = {33},
doi = {10.1002/adhm.71526}
}
EUVIMED